TickerFactsScreenerDevelopers

TherapeuticsMD, Inc. (TXMD) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $4.19M2017: $2.64M2018: $2.74M2019: $6.33M2020: $15.97M2021: $1.40M2022: $1.40M$1.40M
2016Cost of Revenue (USD)2022
Fiscal YearCost of RevenueChange YoY
2022$1.40M-0.4%
2021$1.40M-91.2%
2020$15.97M+152.2%
2019$6.33M+131.4%
2018$2.74M+3.8%
2017$2.64M-37.0%
2016$4.19M—